Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease



Catt, Heather ORCID: 0000-0001-9515-7497, Bodger, Keith ORCID: 0000-0002-1825-3239, Kirkham, Jamie J ORCID: 0000-0003-2579-9325 and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459
(2019) Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease. PHARMACOECONOMICS, 37 (12). 1509 - 1523.

[img] Text
Benefit-risk modelling of biosimilars ACCEPTED VERSION.docx - Accepted Version

Download (630kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 17 Jul 2019 08:41
Last Modified: 09 Nov 2021 09:50
DOI: 10.1007/s40273-019-00826-0
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3050053